NEO · Neogenomics Inc · Analyst Estimates
$17.99
+0.72 (+4.17%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$2.22B
Shares
128.48M
Volume · Oct 28
2.58M
Avg daily vol (3M)
2.18M
Analyst Estimates
Compare analyst forecasts for Neogenomics Inc across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-28 14:50 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.16
|
0.19
|
0.20
|
11
|
0.19
|
0.18
|
0.18
|
0.18
|
0
|
0
|
3
|
3
|
|
Revenue
USD
Publication date not stated |
799.50M
|
805.20M
|
808.52M
|
12
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.27
|
0.34
|
0.41
|
11
|
0.34
|
0.34
|
0.34
|
0.35
|
1
|
1
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
874.70M
|
885.44M
|
903.00M
|
12
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.04
|
0.055
|
0.07
|
11
|
0.055
|
0.054
|
0.054
|
0.052
|
1
|
1
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
205.84M
|
207.33M
|
209.30M
|
10
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
0.06
|
0.07
|
0.08
|
11
|
0.07
|
0.069
|
0.069
|
0.074
|
4
|
4
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
209.50M
|
210.18M
|
211.57M
|
10
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1077183
CUSIP
64049M209
13F (30d)
57 filings
57 filers
Visit website
Investor relations